Acute Kidney Injury Clinical Trials in Dallas, Texas

4 studies are recruiting for acute kidney injury in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

    This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD) will improve survival in patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) when compared to C…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Texas Southwestern Medical Center, Dallas, Texas
    Locations
    36 in total
    Run by
    SeaStar Medical

    See if you can join NCT05758077 on ClinicalTrials.gov

  2. QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

    QUELIMMUNE is FDA-approved under an HDE for the treatment of pediatric patients (weight ≥10kg and age ≤22 years) with AKI due to sepsis or a septic condition on antibiotic therapy and requiring RRT. The purpose of this surveillance registry is to prospectively collect safety data among all patients…

    Stage
    Not phased
    Ages
    Up to 22
    Site
    Children's Medical Center Dallas, Dallas, Texas
    Locations
    15 in total
    Run by
    SeaStar Medical

    See if you can join NCT06517810 on ClinicalTrials.gov

  3. Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

    This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure under…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas
    Locations
    3 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT04982419 on ClinicalTrials.gov

  4. Nafamostat Efficacy in Phase 3 Registrational CRRT Study

    A prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at higher risk for blee…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Baylor University Medical Center, Dallas, Texas
    Locations
    10 in total
    Run by
    Talphera, Inc

    See if you can join NCT06150742 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.